Novo Nordisk
NVO
#15
Rank
โ‚น50.156 T
Marketcap
โ‚น11,316
Share price
2.14%
Change (1 day)
45.61%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.403 T

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are โ‚น1.413 T. In 2023 the company made an earning of โ‚น1.294 T an increase over its 2022 earnings that were of โ‚น821.15 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น1.403 T8.45%
2023 โ‚น1.294 T57.64%
2022 โ‚น821.15 B5.35%
2021 โ‚น779.45 B12.47%
2020 โ‚น693.03 B13.07%
2019 โ‚น612.92 B-3.35%
2018 โ‚น634.17 B1.79%
2017 โ‚น622.99 B4.52%
2016 โ‚น596.04 B9.42%
2015 โ‚น544.74 B8.24%
2014 โ‚น503.28 B3.45%
2013 โ‚น486.51 B19.02%
2012 โ‚น408.77 B15.21%
2011 โ‚น354.82 B17.71%
2010 โ‚น301.42 B24.78%
2009 โ‚น241.56 B10.62%
2008 โ‚น218.36 B55.97%
2007 โ‚น140.00 B7.07%
2006 โ‚น130.76 B18.18%
2005 โ‚น110.64 B11.33%
2004 โ‚น99.38 B
2002 โ‚น65.35 B-14.39%
2001 โ‚น76.33 B-52.82%
2000 โ‚น161.78 B250%
1999 โ‚น46.22 B31.21%
1998 โ‚น35.22 B34.31%
1997 โ‚น26.22 B11.46%
1996 โ‚น23.53 B9.03%
1995 โ‚น21.58 B-3.15%
1994 โ‚น22.28 B-0.67%
1993 โ‚น22.43 B45.38%
1992 โ‚น15.43 B-13.81%
1991 โ‚น17.90 B37.12%
1990 โ‚น13.05 B-0.79%
1989 โ‚น13.16 B26.2%
1988 โ‚น10.42 B24.97%
1987 โ‚น8.34 B-0.9%
1986 โ‚น8.42 B-7.78%
1985 โ‚น9.13 B24.87%
1984 โ‚น7.31 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น101.68 B-107.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น754.14 B-46.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น538.52 B-138.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น566.26 B-59.95%๐Ÿ‡ซ๐Ÿ‡ท France